Geetha A Subramaniam

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use
    Geetha A Subramaniam
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Addiction 105:686-98. 2010
  2. pmc Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth
    Geetha A Subramaniam
    National Institute on Drug Abuse, Bethesda, MD 20892, USA
    J Am Acad Child Adolesc Psychiatry 50:1120-8. 2011
  3. pmc Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder
    Geetha A Subramaniam
    Department of Psychiatry, Johns Hopkins University, Mountain Manor Treatment Center, 3800 Frederick Ave, Baltimore, MD 21229, USA
    Drug Alcohol Depend 101:13-9. 2009
  4. ncbi request reprint Treatment of opioid-dependent adolescents and young adults with buprenorphine
    Geetha A Subramaniam
    Department of Psychiatry, Johns Hopkins University, C O Mountain Manor Treatment Center, 3800 Frederick Avenue, Baltimore, MD 21229, USA
    Curr Psychiatry Rep 11:360-3. 2009
  5. ncbi request reprint Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment
    Geetha A Subramaniam
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA
    J Am Acad Child Adolesc Psychiatry 46:1062-9. 2007
  6. ncbi request reprint Depressive symptoms in adolescents during residential treatment for substance use disorders
    Geetha A Subramaniam
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Addict 13:256-67. 2004

Detail Information

Publications6

  1. pmc The added risk of opioid problem use among treatment-seeking youth with marijuana and/or alcohol problem use
    Geetha A Subramaniam
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Addiction 105:686-98. 2010
    ..To determine the added risk of opioid problem use (OPU) in youth with marijuana/alcohol problem use (MAPU)...
  2. pmc Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth
    Geetha A Subramaniam
    National Institute on Drug Abuse, Bethesda, MD 20892, USA
    J Am Acad Child Adolesc Psychiatry 50:1120-8. 2011
    ..To examine predictors of opioid abstinence in buprenorphine/naloxone (Bup/Nal)-assisted psychosocial treatment for opioid-dependent youth...
  3. pmc Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder
    Geetha A Subramaniam
    Department of Psychiatry, Johns Hopkins University, Mountain Manor Treatment Center, 3800 Frederick Ave, Baltimore, MD 21229, USA
    Drug Alcohol Depend 101:13-9. 2009
    ..To compare the clinical characteristics of treatment-seeking prescription opioid-using adolescents with DSM-IV opioid use disorder (OUD) to those with heroin-using OUD adolescents...
  4. ncbi request reprint Treatment of opioid-dependent adolescents and young adults with buprenorphine
    Geetha A Subramaniam
    Department of Psychiatry, Johns Hopkins University, C O Mountain Manor Treatment Center, 3800 Frederick Avenue, Baltimore, MD 21229, USA
    Curr Psychiatry Rep 11:360-3. 2009
    ....
  5. ncbi request reprint Baseline depressive symptoms predict poor substance use outcome following adolescent residential treatment
    Geetha A Subramaniam
    Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, USA
    J Am Acad Child Adolesc Psychiatry 46:1062-9. 2007
    ..To characterize baseline depressive symptoms among substance-abusing adolescents and determine their association with post residential treatment substance use outcomes...
  6. ncbi request reprint Depressive symptoms in adolescents during residential treatment for substance use disorders
    Geetha A Subramaniam
    Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Am J Addict 13:256-67. 2004
    ..Longer length of stay patients showed significant decline in scores only at Week 5. Females, Caucasians, and high frequency cocaine/opiates users had elevated depressive symptoms, while those with shorter duration of abstinence did not...